Device / Technology News

RSS

Boston University biomedical engineers develop new nanopore method for DNA sequencing

Sequencing DNA could get a lot faster and cheaper - and thus closer to routine use in clinical diagnostics - thanks to a new method developed by a research team based at Boston University. The team has demonstrated the first use of solid state nanopores - tiny holes in silicon chips that detect DNA molecules as they pass through the pore - to read the identity of the four nucleotides that encode each DNA molecule.

20 May 2010

Dynamic testing approach for HIV/AIDS diagnostics

A relatively simple electronic gadget could speed up HIV/AIDS diagnostics and improve accuracy particularly in parts of the world with very limited access to healthcare workers. The device is described in the International Journal of Biomedical Engineering and Technology.

20 May 2010

Studies show positive effects of CPAP on cardiovascular incidence in non-sleepy OSA patients

In non-sleepy patients with obstructive sleep apnea, treatment with continuous positive airway pressure can reduce the incidence of cardiovascular events and hypertension, according to researchers from Spain.

20 May 2010

Ectoin shows positive effect on nanoparticle-induced lung inflammation: Study

bitop AG, which specializes in the development and marketing of Ectoin-containing medical devices, announces that Ectoin significantly reduces nanoparticle-induced inflammatory reaction in rat lungs, one of the animal models for chronic obstructive pulmonary disease. It is the first time that Ectoin has been shown to have such an effect on nanoparticle-induced lung inflammation.

20 May 2010

Home portable monitor testing can be used to diagnose, manage patients with OSA: Study

Patients with suspected obstructive sleep apnea may no longer have to spend an expensive and uncomfortable night at a sleep center to monitor their sleep-disordered breathing. According to new research, those who performed sleep testing in their home with portable monitors showed similar improvements after three months of treatment with continuous positive airway pressure in daytime function as compared to patients who underwent overnight testing in a sleep center.

20 May 2010

New Agilent SurePrint G3 Gene Expression Microarrays introduced

Agilent Technologies Inc. today introduced Agilent SurePrint G3 Gene Expression Microarrays, providing up to one million features per standard 1-by-3-inch slide for added throughput, unique coverage which includes both coding and non-coding RNA, and cost effectiveness.

20 May 2010

Stryker resolves FDA Warning Letters

Stryker Corporation today announced that the U.S. Food and Drug Administration (FDA) has informed the Company that the actions undertaken to address issues raised in two Warning Letters received in 2007 and 2009 are sufficient.

From Stryker 20 May 2010

MEDRAD's Intego PET Infusion System integrated with Pinestar's Nuclear Medicine Information System

Today, MEDRAD, Inc. and Pinestar Technology, Inc. announced plans to enable data communication between MEDRAD's Intego™ PET Infusion System and Pinestar's Nuclear Medicine Information System (NMIS). The companies are closing the information gap between state of the art infusion systems and the latest information systems, and thus adding to the workflow benefits of automated FDG infusion.

20 May 2010

CMS to spend $73 million over 5 years to improve public websites

Washington Business Journal: "The Centers for Medicare & Medicaid Services has awarded Fairfax-based CGI Federal Inc. a five-year contract worth $73.2 million to continue its modernization, application management and maintenance efforts on three external websites that provide information to 44 million beneficiaries and millions more health care providers."

20 May 2010

Initial results of MUSIC Trial using PD2i in chronic heart failure patients released

David H. Fater, CEO of Vicor Technologies, Inc., today announced the initial results of a study designed to analyze data from the Merte Subita en Insufficiencia Cardiaca Trial using its PD2i- algorithm and software. Vicor Technologies is a biotechnology company focused on the development of innovative, non-invasive medical devices using its patented, proprietary PD2i- nonlinear algorithm and software.

20 May 2010

Luminex, HTG launch qBead Gene Expression Assay

Luminex Corporation, the worldwide leader in multiplexed solutions, and High Throughput Genomics, Inc. (HTG), provider of the quantitative Nuclease Protection Assay (qNPA™), today launched a new custom gene expression product, the qBead Gene Expression Assay (qBead Assay). The companies co-developed the product and have signed an exclusive distribution agreement in which Luminex will begin offering it to the research community.

From Luminex 20 May 2010

New online diagnosis tool offers prescriptions in a hurry

News outlets report on the expanding online relationship between doctors and patients.

20 May 2010

Medtronic commences treatment in RESCUE trial of Valiant Thoracic Stent Graft with Captivia Delivery System

Further demonstrating its commitment to proving the benefits of minimally-invasive procedures, Medtronic, Inc., today announced that the first patient has been treated with the company's Valiant® Thoracic Stent Graft with the Captivia Delivery System in Medtronic's RESCUE Clinical Study.

20 May 2010

AIR Trial demonstrates benefits of BT in asthma patients

Asthmatx Inc., today presented positive five-year data from the Asthma Intervention Research Trial, which evaluated the safety of bronchial thermoplasty with the Alair System. The data demonstrated the absence of clinical complications and the maintenance of stable lung function over a five year period post-BT in patients with moderate to severe asthma.

20 May 2010

FDA grants 510(k) market clearance for EraGen's MultiCode-RTx HSV 1&2 Kit

EraGen Biosciences Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) market clearance for EraGen's MultiCode®-RTx HSV 1&2 Kit.

20 May 2010

St. Elizabeth Regional Health selects TeleHealth Services as compliance partner in new facility

TeleHealth Services, the nation's leading provider of health care grade televisions and interactive patient education solutions to hospitals, has been selected by St. Elizabeth Regional Health as a compliance partner in their new facility, St. Elizabeth East, located at 1701 S. Creasy Lane in Lafayette. St. Elizabeth East opened on February 25, 2010 and will benefit from TeleHealth's interactive educational solutions in an effort to increase patient satisfaction and create a patient-focused, technologically advanced facility.

19 May 2010

maxIT Healthcare, Ingenuity Solutions Group enter definitive agreement to merge

maxIT Healthcare, LLC and Ingenuity Solutions Group, Inc. announced today that they have entered into a definitive agreement, under which the companies will be combined as maxIT Healthcare. The combined company is now better positioned to extend its presence throughout the healthcare IT professional services market, particularly in the area of Enterprise Resource Planning (ERP) system solutions.

19 May 2010

Essen BioScience launches CellPlayer Cell Migration 96-well assay kit

Essen BioScience Inc., a global provider of life science research tools and discovery services, today announced the launch of its CellPlayer™ Cell Migration 96-well assay kit for the IncuCyte™ Live-Cell Imaging System. The expanding line of kinetic CellPlayer assays for the IncuCyte also includes a co-culture assay for Angiogenesis.

From Sartorius 19 May 2010

Boston Scientific announces U.S., European launches of Sterling SL PTA Balloon Dilatation Catheter

Boston Scientific Corporation today announced the U.S. and European launches of the Sterling® SL PTA Balloon Dilatation Catheter, a high-performance balloon dilatation catheter designed for use in peripheral angioplasty procedures below the knee. The Company plans to launch the product immediately in both markets.

19 May 2010

ABBOTT PRISM Chagas test receives FDA approval

Abbott received Biologic License Application (BLA) approval from the United States Food and Drug Administration (FDA) for the ABBOTT PRISM Chagas test. The test is a fully automated blood screening assay that can detect antibodies to Trypansoma cruzi (T. cruzi), a parasite found only in the Americas and most commonly acquired through contact with the blood-sucking triatomine or "kissing bug."

19 May 2010

Device / Technology News

Boston University biomedical engineers develop new nanopore method for DNA sequencing

Dynamic testing approach for HIV/AIDS diagnostics

Studies show positive effects of CPAP on cardiovascular incidence in non-sleepy OSA patients

Ectoin shows positive effect on nanoparticle-induced lung inflammation: Study

Home portable monitor testing can be used to diagnose, manage patients with OSA: Study

New Agilent SurePrint G3 Gene Expression Microarrays introduced

Stryker resolves FDA Warning Letters

MEDRAD's Intego PET Infusion System integrated with Pinestar's Nuclear Medicine Information System

CMS to spend $73 million over 5 years to improve public websites

Initial results of MUSIC Trial using PD2i in chronic heart failure patients released

Luminex, HTG launch qBead Gene Expression Assay

New online diagnosis tool offers prescriptions in a hurry

Medtronic commences treatment in RESCUE trial of Valiant Thoracic Stent Graft with Captivia Delivery System

AIR Trial demonstrates benefits of BT in asthma patients

FDA grants 510(k) market clearance for EraGen's MultiCode-RTx HSV 1&2 Kit

St. Elizabeth Regional Health selects TeleHealth Services as compliance partner in new facility

maxIT Healthcare, Ingenuity Solutions Group enter definitive agreement to merge

Essen BioScience launches CellPlayer Cell Migration 96-well assay kit

Boston Scientific announces U.S., European launches of Sterling SL PTA Balloon Dilatation Catheter

ABBOTT PRISM Chagas test receives FDA approval

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Latest News